HIND
Vyome Holdings, Inc.
NASDAQ: HIND · HEALTHCARE · BIOTECHNOLOGY
$2.03
-0.49% today
Updated 2026-04-30
Market cap
$15.09M
P/E ratio
—
P/S ratio
47.20x
EPS (TTM)
$-4.86
Dividend yield
—
52W range
$2 – $56
Volume
0.0M
Vyome Holdings, Inc. (HIND) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,707.00%
ROE
0.00%
ROA
-43.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-17.69M | — | — | — |
| 2007 | — | $-28.58M | — | — | — |
| 2008 | — | $-37.87M | — | — | — |
| 2009 | — | $-31.93M | — | — | — |
| 2010 | — | $-17.35M | — | — | — |
| 2011 | — | $-26.00M | — | — | — |
| 2012 | $312000.00 | $-23.46M | 25.64% | -7,227.24% | -7,519.23% |
| 2013 | — | $-25.78M | — | — | — |
| 2014 | — | $-26.13M | — | — | — |
| 2015 | $292000.00 | $-25.50M | 57.19% | -9,543.49% | -8,732.53% |
| 2016 | $786660.00 | $-23.36M | 45.15% | -2,897.77% | -2,969.62% |
| 2017 | $1.29M | $-33.82M | 27.25% | -2,440.10% | -2,627.34% |
| 2018 | $606710.00 | $-81.15M | 72.92% | -6,353.28% | -13,375.68% |
| 2019 | $15.09M | $-74.21M | 61.67% | -162.11% | -491.80% |
| 2020 | $11.30M | $-21.63M | 55.42% | -110.25% | -191.43% |
| 2021 | $13.60M | $-63.15M | 61.38% | -425.60% | -464.31% |
| 2022 | $11.24M | $-46.21M | 60.52% | -240.91% | -411.16% |
| 2023 | $8.68M | $-11.39M | 63.93% | -168.69% | -131.22% |
| 2024 | $8.01M | $-7.13M | 63.17% | -96.53% | -89.06% |
| 2025 | $319714.00 | $-10.26M | 64.68% | -859.22% | -3,209.75% |